Abstract:Immunotoxins are emerging candidates for cancer therapeutics. These biomolecules consist of a cell-targeting protein combined to a polypeptide toxin. Associations of both entities can be achieved either chemically by covalent bonds or genetically creating fusion proteins. However, chemical agents can affect the activity and/or stability of the conjugate proteins, and additional purification steps are often required to isolate the final conjugate from unwanted byproducts. As for fusion proteins, they often suffer from low solubility and yield. In this report, we describe a straightforward conjugation process to generate an immunotoxin using coassociating peptides (named K3 and E3), originating from the tetramerization domain of p53. To that end, a nanobody targeting the human epidermal growth factor receptor 2 (nano-HER2) and a protein toxin fragment from Pseudomonas aeruginosa exotoxin A (TOX) were genetically fused to the E3 and K3 peptides. Entities were produced separately in Escherichia coli in soluble forms and at high yields. The nano-HER2 fused to the E3 or K3 helixes (nano-HER2-E3 and nano-HER2-K3) and the coassembled immunotoxins (nano-HER2-K3E3-TOX and nano-HER2-E3K3-TOX) presented binding specificity on HER2-overexpressing cells with relative binding constants in the low nanomolar to picomolar range. Both toxin modules (E3-TOX and K3-TOX) and the combined immunotoxins exhibited similar cytotoxicity levels compared to the toxin alone (TOX). Finally, nano-HER2-K3E3-TOX and nano-HER2-E3K3-TOX evaluated on various breast cancer cells were highly potent and specific to killing HER2-overexpressing breast cancer cells with IC50 values in the picomolar range. Altogether, we demonstrate that this noncovalent conjugation method using two coassembling peptides can be easily implemented for the modular engineering of immunotoxins targeting different types of cancers.

[Construction and expression of repeats of HER-2 mimetic peptide]

Humoral immune response against HER-2 induced by immunization with peptide fusion protein

A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.

Cloning and Prokaryotic Expression of HER-2/neu Extracellular Domain

Construction of multiple antigenic peptide and the immunity analysis

[Constructing the Recombinant of Pet28a-Tat-lacz].

Expression of T and B cells combined epitopes protein of Leptospira interrogans and the immunity analysis

Epitope Prediction of Vibrio Vulnificus Cytolysin and Construction of Phage Display Peptides

Construction of an Eukaryotic Expression Plasmid for Short Peptides Used in DNA Immunization

Peptidomimetic-based antibody surrogate for HER2

Expression and Immunogenicity of the Eukaryotic Vector of Mimotope Mgc Derived from Glycoprotein C of Herpes Simplex Virus

Construction and Identification of Five Mutants of Hil-18 in Expression Plasmid and Their Expression in BxPC-3 Cells

Construction of the eukaryotic expression vector of duck HBV polymerase binding mimic peptide

Expression, Purification and Renaturation of HER-2/neu RLD Protein

Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors.

Zwitterionic Peptide Pendant As a Homing Agent to Achieve Lymphatic Targeting Antigen-Specific Immunotherapy of Allergenic Protein

Induction of Anti-Egfr Immune Response with Mimotopes Identified from a Phage Display Peptide Library by Panitumumab

Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins

Expression, Purification, and Renaturation of a Recombinant Peptide-Based HIV Vaccine in Escherichia Coli.